Sign In
Buy EMBC
$3.32
-0.170 (-4.87%)
At Close: Jun 03, 2026
embecta Announces Quarterly Cash Dividend
06:00am, Tuesday, 26'th Nov 2024
PARSIPPANY, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstandi
UPDATE - embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
05:31pm, Tuesday, 12'th Nov 2024
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call
embecta to Report Fiscal Fourth Quarter and Full Year 2024 Financial Results
05:00pm, Tuesday, 12'th Nov 2024
PARSIPPANY, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call
embecta Celebrates National Diabetes Awareness Month by Ringing Nasdaq Closing Bell
06:30am, Thursday, 07'th Nov 2024
embecta will be joined by diabetes advocacy groups to ring the Nasdaq Closing Bell today in recognition of National Diabetes Awareness Month in November.
Embecta Stock Gains on FDA Clearance for Type 2 Diabetes Insulin Pump
09:26am, Wednesday, 04'th Sep 2024
EMBC's shares close higher following FDA clearance for its disposable patch pump for insulin delivery, expanding the target market with its availability for type 2 diabetes.
embecta has received 510(k) clearance from the FDA for its proprietary disposable insulin delivery system, a patch pump with a 300-unit insulin reservoir.
embecta to Participate in Investor Events
05:00pm, Thursday, 22'nd Aug 2024
PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that manage
Embecta Corp. (EMBC) Just Overtook the 200-Day Moving Average
10:30am, Monday, 12'th Aug 2024
From a technical perspective, Embecta Corp. (EMBC) is looking like an interesting pick, as it just reached a key level of support. EMBC recently overtook the 200-day moving average, and this suggests
Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript
10:39am, Friday, 09'th Aug 2024
Embecta Corp. (NASDAQ:EMBC ) Q3 2024 Earnings Conference Call August 9, 2024 8:00 AM ET Company Participants Pravesh Khandelwal - VP & Head of IR Dev Kurdikar - President, CEO & Director Jake Elguicze
Embecta Corp. (EMBC) Tops Q3 Earnings and Revenue Estimates
08:41am, Friday, 09'th Aug 2024
Embecta Corp. (EMBC) came out with quarterly earnings of $0.74 per share, beating the Zacks Consensus Estimate of $0.48 per share. This compares to earnings of $0.69 per share a year ago.
Embecta Corp. Reports Third Quarter Fiscal 2024 Financial Results
06:30am, Friday, 09'th Aug 2024
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and ni
embecta Announces Quarterly Cash Dividend
06:00am, Friday, 09'th Aug 2024
PARSIPPANY, N.J., Aug. 09, 2024 (GLOBE NEWSWIRE) -- The Board of Directors of Embecta Corp. (“embecta”) (Nasdaq: EMBC) has declared a quarterly cash dividend of $0.15 for each issued and outstandi
Genpact Supports embecta's Spin-Off into an Independent Diabetes Care Company
08:05am, Monday, 29'th Jul 2024
Genpact's deep domain knowledge and data expertise enables embecta's vision to make a meaningful impact in the healthcare sector NEW YORK , July 29, 2024 /PRNewswire/ -- Genpact (NYSE: G), a global p
embecta to Report Fiscal Third Quarter 2024 Financial Results
05:00pm, Thursday, 18'th Jul 2024
PARSIPPANY, N.J., July 18, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call
PARSIPPANY, N.J., June 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, presented two abstracts at
